[Federal Register Volume 89, Number 192 (Thursday, October 3, 2024)]
[Notices]
[Pages 80573-80574]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Heritable Disorders in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Heritable Disorders in 
Newborns and Children (ACHDNC or Committee) has scheduled a public 
meeting. Information about ACHDNC and the agenda for this meeting can 
be found on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.

DATES: Thursday, November 14, 2024, from 10 a.m. to 4 p.m. eastern time 
(ET).

ADDRESSES: This meeting will be held via webinar. While this meeting is 
open to the public, advance registration is

[[Page 80574]]

required. Please visit the ACHDNC website for information on 
registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. Register no later than 12:00 p.m. ET on November 
13, 2024. Instructions on how to access the meeting via webcast will be 
provided upon registration.

FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child 
Health Bureau, HRSA, 5600 Fishers Lane, Room, Rockville, Maryland 
20857; 301-443-8335; or <a href="/cdn-cgi/l/email-protection#f1b0b2b9b5bfb2b199838290df969e87"><span class="__cf_email__" data-cfemail="4504060d010b06052d3736246b222a33">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of Health and Human Services (Secretary) on the 
development of newborn screening activities, technologies, policies, 
guidelines, and programs for effectively reducing morbidity and 
mortality in newborns and children having, or at risk for, heritable 
disorders. ACHDNC reviews and reports regularly on newborn and 
childhood screening practices, recommends improvements in the national 
newborn and childhood screening programs, and fulfills requirements 
stated in the authorizing legislation. In addition, ACHDNC's 
recommendations regarding inclusion of additional conditions for 
screening on the Recommended Uniform Screening Panel, following 
adoption by the Secretary, are evidence-informed preventive health 
services provided for in the comprehensive guidelines supported by HRSA 
pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 
300gg-13). Under this provision, non-grandfathered group health plans 
and health insurance issuers offering non-grandfathered group or 
individual health insurance are required to provide insurance coverage 
without cost-sharing (a co-payment, co-insurance, or deductible) for 
preventive services for plan years (i.e., policy years) beginning on or 
after the date that is 1 year from the Secretary's adoption of the 
condition for screening.
    During the November 14, 2024, meeting, ACHDNC will hear from 
experts in the fields of public health, medicine, heritable disorders, 
rare disorders, and newborn screening. Possible agenda items may 
include the following topics:
    (1) An update on the development of a newborn screening family 
outcomes tool,
    (2) A panel presentation on funding opportunities for research that 
includes the lived experience,
    (3) A presentation on the Newborn Screening Information Center, and
    (4) An update on Recommended Uniform Screening Panel condition 
nomination submissions.
    Agenda items are subject to change as priorities dictate. 
Information about ACHDNC, including a roster of members and past 
meeting summaries, is available on the ACHDNC website listed above.
    Members of the public will have the opportunity to provide comments 
on any of the above agenda items. Public participants may request to 
provide general oral comments and may submit written statements in 
advance of the scheduled meeting. Oral comments will be honored in the 
order they are requested and may be limited as time allows. Requests to 
provide a written statement or make oral comments to ACHDNC must be 
submitted via the registration website by 12:00 p.m. ET on Thursday, 
October 31, 2024. Written comments will be shared with the Committee 
prior to the meeting so they have an opportunity to consider them in 
advance of the meeting.
    Individuals who need special assistance or another reasonable 
accommodation should notify Leticia Manning at the address and phone 
number listed above at least 10 business days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-22733 Filed 10-2-24; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>